Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hauser

Showing results (311-320 of 419) with videos related to

Pageof 42
Sort By:
Ebiomedicine|June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trialsAmit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 24, 2018
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1aEva Havrdová, Douglas L Arnold, Amit Bar-Or, et al.
The Lancet. Neurology|April 17, 2007
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoringLudwig Kappos, David Bates, Hans-Peter Hartung, et al.
Neurology|December 15, 2004
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosisB A C Cree, O Khan, D Bourdette, et al.
Human Molecular Genetics|March 17, 2009
Pathway and network-based analysis of genome-wide association studies in multiple sclerosisSergio E Baranzini, Nicholas W Galwey, Joanne Wang, et al.
Brain : a Journal of Neurology|December 29, 2020
Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosisKicheol Kim, Anne-Katrin Pröbstel, Ryan Baumann, et al.
Genes and Immunity|June 2, 2006
Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosisS Schmidt, M A Pericak-Vance, S Sawcer, et al.
Human Genetics|January 30, 2010
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityRebecca L Zuvich, Jacob L McCauley, Jorge R Oksenberg, et al.
Plos One|August 4, 2020
Imaging correlates of visual function in multiple sclerosisEduardo Caverzasi, Christian Cordano, Alyssa H Zhu, et al.
Nature|August 9, 2019
Opposing T cell responses in experimental autoimmune encephalomyelitisNaresha Saligrama, Fan Zhao, Michael J Sikora, et al.
Pageof 42

Showing results (311-320 of 419) with videos related to

Sort By:
Pageof 42
Ebiomedicine|June 24, 2023
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trialsAmit Bar-Or, Gian-Andrea Thanei, Christopher Harp, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 24, 2018
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1aEva Havrdová, Douglas L Arnold, Amit Bar-Or, et al.
The Lancet. Neurology|April 17, 2007
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoringLudwig Kappos, David Bates, Hans-Peter Hartung, et al.
Neurology|December 15, 2004
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosisB A C Cree, O Khan, D Bourdette, et al.
Human Molecular Genetics|March 17, 2009
Pathway and network-based analysis of genome-wide association studies in multiple sclerosisSergio E Baranzini, Nicholas W Galwey, Joanne Wang, et al.
Brain : a Journal of Neurology|December 29, 2020
Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosisKicheol Kim, Anne-Katrin Pröbstel, Ryan Baumann, et al.
Genes and Immunity|June 2, 2006
Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosisS Schmidt, M A Pericak-Vance, S Sawcer, et al.
Human Genetics|January 30, 2010
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityRebecca L Zuvich, Jacob L McCauley, Jorge R Oksenberg, et al.
Plos One|August 4, 2020
Imaging correlates of visual function in multiple sclerosisEduardo Caverzasi, Christian Cordano, Alyssa H Zhu, et al.
Nature|August 9, 2019
Opposing T cell responses in experimental autoimmune encephalomyelitisNaresha Saligrama, Fan Zhao, Michael J Sikora, et al.
Pageof 42